These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 30343433

  • 1. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, De Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G.
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [Abstract] [Full Text] [Related]

  • 2. Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage.
    Pietroboni AM, Colombi A, Carandini T, Sacchi L, Fenoglio C, Marotta G, Arighi A, De Riz MA, Fumagalli GG, Castellani M, Bozzali M, Scarpini E, Galimberti D.
    Alzheimers Res Ther; 2022 Feb 12; 14(1):33. PubMed ID: 35151361
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
    Pietroboni AM, Colombi A, Contarino VE, Russo FML, Conte G, Morabito A, Siggillino S, Carandini T, Fenoglio C, Arighi A, De Riz MA, Arcaro M, Sacchi L, Fumagalli GG, Bianchi AM, Triulzi F, Scarpini E, Galimberti D.
    Eur Radiol; 2023 Aug 12; 33(8):5368-5377. PubMed ID: 36562783
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 11C-Pittsburgh Compound B and 18F-Flutemetamol White Matter Binding in PET.
    Zeydan B, Schwarz CG, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR, Kantarci K, Lowe VJ.
    J Nucl Med; 2022 Aug 12; 63(8):1239-1244. PubMed ID: 34916245
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
    Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.
    AJR Am J Roentgenol; 2017 Oct 12; 209(4):889-894. PubMed ID: 28705068
    [Abstract] [Full Text] [Related]

  • 12. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
    Elkady AM, Wu Z, Leppert IR, Arnold DL, Narayanan S, Rudko DA.
    Mult Scler Relat Disord; 2021 Nov 12; 56():103309. PubMed ID: 34688179
    [Abstract] [Full Text] [Related]

  • 13. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
    Bodini B, Poirion E, Tonietto M, Benoit C, Palladino R, Maillart E, Portera E, Battaglini M, Bera G, Kuhnast B, Louapre C, Bottlaender M, Stankoff B.
    J Nucl Med; 2020 Jul 12; 61(7):1043-1049. PubMed ID: 32005777
    [Abstract] [Full Text] [Related]

  • 14. Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.
    Zeydan B, Lowe VJ, Schwarz CG, Przybelski SA, Tosakulwong N, Zuk SM, Senjem ML, Gunter JL, Roberts RO, Mielke MM, Benarroch EE, Rodriguez M, Machulda MM, Lesnick TG, Knopman DS, Petersen RC, Jack CR, Kantarci K, Kantarci OH.
    Mult Scler; 2018 May 12; 24(6):739-749. PubMed ID: 28474977
    [Abstract] [Full Text] [Related]

  • 15. Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain.
    Bural G, Torigian D, Basu S, Houseni M, Zhuge Y, Rubello D, Udupa J, Alavi A.
    Nucl Med Commun; 2015 Dec 12; 36(12):1249-52. PubMed ID: 26426967
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.
    Datta G, Colasanti A, Kalk N, Owen D, Scott G, Rabiner EA, Gunn RN, Lingford-Hughes A, Malik O, Ciccarelli O, Nicholas R, Nei L, Battaglini M, De Stefano N, Matthews PM.
    J Nucl Med; 2017 Sep 12; 58(9):1477-1482. PubMed ID: 28302760
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.